NCT04961060View on ClinicalTrials.gov

Drivers of Eosinophilic COPD Exacerbations

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

January 31, 2025

Conditions
COPD ExacerbationEosinophilia
Trial Locations (2)

6229 GT

NOT_YET_RECRUITING

University Maastricht, Maastricht

9713 GZ

RECRUITING

Univesity Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Maastricht University

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT04961060 - Drivers of Eosinophilic COPD Exacerbations | Biotech Hunter | Biotech Hunter